Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Overview of Anaphylaxis

1,014 views

Published on

Overview of anaphylaxis. General principles

Published in: Health & Medicine
  • Be the first to comment

Overview of Anaphylaxis

  1. 1. Anaphylaxis
  2. 2. Introduction Immediate hypersensitivit y Antibodymediated immune complex diseases T cell-mediated diseases Mast cell release histamine and other mediators Antibodies directed against cell or tissue antigens Antibodyantigen complex deposit in blood vessels Reactions of T lymphocytes
  3. 3. Terminology • IgE-based antibody Responses are common physiologically in parasitic infections. • Atopic individual Genetic in an individual which is predisposition to suffer from allergies. They produce IgE responses against a number of non-parasitic antigens that induce either no antibody response or antibody response of a different isotype.
  4. 4. Terminology Beta-blockers (beta-adrenergic blocking antagonist) are drugs that treat several conditions: • Hypertension • Angina • Some abnormal heart rhythms • Myocardial infarction • Anxiety • Migraine • Glaucoma
  5. 5. Objectives 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. What is anaphylaxis? Etiology Pathophysiology Signs and symptoms Risk factors. Complications Diagnosis Treatment and management Prevention First aid for Anaphylactic patients.
  6. 6. Anaphylaxis O Ana (without), phylaxis (protection). O A serious acute allergic reaction that cause systemic effects and may cause death. (Type I Hypersensitivity) O Allergen must be systemically absorbed (Ingestion or injection) to cause Anaphylaxis
  7. 7. Etiology Causes of anaphylaxis in a study of 266 patients (Data from Kemp et al) Food 2% 7% Idiopathic 34% 20% 37% Drugs Exercise Latex, hormons, insect bites
  8. 8. Etiology Venoms Common Drugs Nuts Wasps Beta-Lactam antibiotics such as penicillin seafood Bees Acetylsalicylic acid Dairy Products Yellow-jackets Trimethoprim sulfamethoxaz ole Egg Hornets Vancomycin wheat -------------- NSAIDs Latex Not associated with death FOOD
  9. 9. Pathophysiology • First exposure  Activation of TH2 cell → Stimulate IgE switiching Allergen TH2 Cell B Cell
  10. 10. Pathophysiology • First exposure  IgE production IgE secreting B cell IgE
  11. 11. Pathophysiology •Second exposure Second exposure First exposure  Antigen recognition IgE bind to mast cell   Activation of mast cell to release   histamine and other mediators Allergen Mast cell Mediators FcɛRI IgE
  12. 12. Pathophysiology Mediators Vascoactive aminase & lipid Cytokines Immediate hypersensitivity reaction (minutes) Late phase reaction (6-24 hours)
  13. 13. Summary These reaction can affect single tissue or organ (Eczema, asthma and hay fever) - Or multiple ones (anaphylaxis) depending on the re-exposure of allergen. Note: This process normally mediated by IgG or immune complex
  14. 14. Result Mediators Downstream activation of phospholipase A2 Inflammatory cytokine Releasing • Histamine • Tryptase, • Carboxypeptidas eA • Proteoglycans (Early Phase) • Prostaglandins, • Leukotrienes • plateletactivating factor (Early Phase) • TNF alpha • IL-13 • (Act as late phase)
  15. 15. Outcome Stimuli Outcome Histamine Vasodilation, increases vascular permeability, heart rate, cardiac contraction, and glandular secretion. Prostaglandin D2 Bronchoconstrictor, pulmonary and coronaryvasoconstrictor, and peripheral vasodilator Leukotrienes Bronchoconstriction, increase vascular permeability, and promote airway remodeling Platelet-activating Bronchoconstrictor and increases vascular factor permeability. TNF- alpha Activate neutrophils, recruits other effector cells, and enhances chemokine synthesis
  16. 16. Signs & Symptoms Skin Itching flushing hives (urticaria) swelling
  17. 17. Signs & Symptoms Eyes Itching tearing redness swelling around the eyes
  18. 18. Signs & Symptoms Nose & mouth Sneezing runny nose swelling of the tongue nasal congestion metallic taste
  19. 19. Signs & Symptoms Lungs and throat Difficulty breathing coughing chest tightness wheezing or other sounds increased mucus production throat swelling or itching change in voice or a sensation of choking
  20. 20. Signs & Symptoms Heart and circulation Dizziness weakness rapid, slow, or irregular heart rate fainting low blood pressure
  21. 21. Signs & Symptoms Digestive system Nausea vomiting cramps diarrhea
  22. 22. Signs & Symptoms Nervous system Anxiety confusion sense of impending doom
  23. 23. Hypotension Summary Respiratory Cardiovascular cardiovascular collapse cough tachycardia broncho spasm wheezing Rhinitis flushing Anaphylaxis angioed ema Skin diffuse erythema Several systems urticaria stridor hoarseness
  24. 24. Risk factor • History of anaphylaxis, atopy, or asthma. (Some not) • Food allergy • Repeated latex exposure • β-blocker use may limit the effectiveness of epinephrine, resulting in protracted anaphylaxis and severe hypotension
  25. 25. Complications • Hypoxemia and end-organ damage due to hypoxia • Shock • Cardiac arrest • Death
  26. 26. Diagnosis
  27. 27. Diagnosis Diagnosis based on: • Clinical presentation: Involvement of any two or more body systems is observed • History of exposure to a possible triggers laboratory tests.
  28. 28. Diagnostic test • ECG to eliminate other causes of chest pain. • Radiographs for chest and neck considering an alternate diagnosis of epiglottitis or other acute respiratory condition
  29. 29. Diagnostic test • Serum tryptase released along with histamine can be measureable. • Serum electrolytes • CBC • Clotting studies • Prick test exclude electrolyte disturbances or bleeding that is causing hypovolemia
  30. 30. Treatment and management • Aim: 1. Full resolution of all associated symptoms. 2. Saving the patient's life in serious reactions 3. Prevention of further anaphylactic reactions.
  31. 31. Treatment and management First linetherapy Second-line therapy counteract treat hypotension persistent bronchospasm Epinephrine H1 Diphenhydramine O2 Trendeleburg Administration position Supplemental H2 Cimetidine and O2 ranitidine Albuterol IV adminstration IV fluids Methylprednis olone Glucagon for patient taking Beta blockers Corticosteriods
  32. 32. Treatment and management 1- Epinephrine - ANTAGONIST increase BP and Bradycardia to counter shock - Inhibit further mast cell degranulation 2- Antihistamine 3to reduce inflammation of your air passages and improve breathing O2 to help compensate for restricted breathing 4- Albuterol to relieve breathing symptoms
  33. 33. Treatment and management Epinephrine Action speed When is it used? Dose Intramuscular Has rapid onset action Severe, Anterolateral of the middle thigh 6< 0.15 mL 6-12 0.3mL 12< 0,5 mL Intravenous Has rapid onset action Severe, should be carefully monitored Slow intravenous injection
  34. 34. Prevention • Allergen avoidance is the best preventive measure. 1- Diet 2-Physical activity 3- Carry auto-injector 4-Environment 5-Medication 6-Immunization *Education is recommended about how to deal with this disease.
  35. 35. First aid • Aim: 1. limiting allergic response. 2. decreasing the severity of the symptoms.
  36. 36. First aid Place patient in Trendelenburg position. Establish and maintain airway. Give oxygen via nasal cannula as needed. Place a tourniquet above the reaction site. Epinephrine at the site of antigen injection. Start IV to rise BP.
  37. 37. Refernces • • • • • • • Abbas: Basic immunology BNF – 2013 Clincalkey.com Kumar and Clarks Clinical Medicine MDCONSULT.COM AUSTRALIAN RESUSCITATION COUNCIL http://www.resus.org.au/policy/guidelines/section_9/anaphyl axis_first_aid_management.htm

×